13,464 results match your criteria Cardiogenic Shock


Renin as a Marker of Tissue-Perfusion and Prognosis in Critically Ill Patients.

Crit Care Med 2019 Feb;47(2):152-158

Department of Intensive Care, Cliniques Universitaires de Bruxelles-Hôpital Erasme, Brussels, Belgium.

Objectives: To characterize renin in critically ill patients. Renin is fundamental to circulatory homeostasis and could be a useful marker of tissue-perfusion. However, diurnal variation, continuous renal replacement therapy and drug-interference could confound its use in critical care practice. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/CCM.0000000000003544DOI Listing
February 2019

Safe Exchange of a Transfemoral Impella Pump.

Cardiovasc Revasc Med 2018 Dec 19. Epub 2018 Dec 19.

Cardiac Arrest Center, Advanced Heart Failure Unit, Department of Cardiology and Angiology, Hannover Medical School, Hannover, Germany.

Mechanical circulatory support with the Impella pump is established in many centers treating patients with cardiogenic shock. While Impella pumps usually run very stable, it may still be possible that one needs to remove the pump for using the same vascular access for different reasons. Unfortunately, until now it had been nearly impossible to remove the pump while preserving arterial access without severe bleeding. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.carrev.2018.12.006DOI Listing
December 2018

Management issues during postinfarction ventricular septal defect and role of perioperative optimization: A case series.

Ann Card Anaesth 2019 Jan-Mar;22(1):30-34

Department of Cardiothoracic Surgery, Dubai Hospital, Al Baraha, Dubai, United Arab Emeritus.

The development of a myocardial infarction ventricular septal rupture is a rare fatal complication, and the surgical repair is the treatment of choice. In most of the scenarios, the operation will be done as an emergency procedure that carries high mortality. Prognosis of these patients depends on prompt echocardiographic diagnosis and the proactive medical and surgical therapy. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4103/aca.ACA_189_17DOI Listing
January 2019

Effect of Potent P2Y Inhibitors on Ventricular Arrhythmias and Cardiac Dysfunction in Coronary Artery Disease: A Systematic Review and Meta-Analysis.

Biomed Res Int 2018 17;2018:8572740. Epub 2018 Dec 17.

Emergency & Critical Care Center, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.

Background: Previous studies have shown that P2Y receptor inhibitors might prevent ventricular arrhythmias and cardiac dysfunction in patients with coronary artery disease. However, few studies have focused on comparison of the efficacy of novel oral potent P2Y receptor inhibitors with clopidogrel on these outcomes.

Methods And Results: We performed a systematic review and meta-analysis of randomized controlled trials (RCTs) that were published in electronic databases of MEDLINE, EMBASE, Cochrane Central Register of Clinical Trials, and ClinicalTrials. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1155/2018/8572740DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6311824PMC
December 2018

In-hospital outcome of patients with post-MI VSD: a single-center study.

Kardiochir Torakochirurgia Pol 2018 Dec 31;15(4):227-232. Epub 2018 Dec 31.

Department of Cardiology, Tabriz University of Medical Science, Tabriz, Iran.

Introduction: Ventricular septal defect (VSD) is a rare but life-threatening complication of acute myocardial infarction (AMI). There is a paucity of data regarding the natural history of this devastating complication of myocardial infarction in the Middle East region with restricted financial resources and unsolved major health problems.

Aim: To evaluate the clinical presentation and in-hospital outcome of patients with post-infarction VSD over a 10-year period in a tertiary center in northwest Iran. Read More

View Article

Download full-text PDF

Source
https://www.termedia.pl/doi/10.5114/kitp.2018.80918
Publisher Site
http://dx.doi.org/10.5114/kitp.2018.80918DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6329881PMC
December 2018
2 Reads

Size of Anterior Wall Acute Myocardial Infarction Treated by Primary Percutaneous Coronary Intervention in United States Versus Europe/Australia Versus India (from the CRISP-AMI Randomized Controlled Trial).

Am J Cardiol 2019 Jan 4. Epub 2019 Jan 4.

Duke Clinical Research Institute, Durham, North Carolina; Duke University Medical Center, Durham, North Carolina. Electronic address:

International variability in infarct size following acute anterior ST-elevation myocardial infarction without shock treated with primary percutaneous coronary intervention (PCI) has been little studied. Patients enrolled in the Counterpulsation to Reduce Infarct Size pre-PCI for Acute Myocardial Infarction international randomized trial were analyzed according to their region of enrollment: United States (US) (n = 60), Europe/Australia (EU/AU) (n = 104), or India (n = 123). Cardiac magnetic resonance imaging was performed 3-5 days after PCI to assess infarct size, expressed as percentage of left ventricular mass, and analyzed by an imaging core laboratory. Read More

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S00029149193003
Publisher Site
http://dx.doi.org/10.1016/j.amjcard.2018.12.027DOI Listing
January 2019
1 Read

Recurrent Cardiogenic Shock Associated with Cannabis Use: Report of a Case and Review of the Literature.

J Emerg Med 2019 Jan 10. Epub 2019 Jan 10.

San Diego Cardiac Center, San Diego, California; Sharp Healthcare, San Diego, California.

Background: The United States has recently undergone increases in the legalization and use of marijuana. There have been previous reports on the association of cannabis use and myocardial dysfunction, however, few on the association with acute stress cardiomyopathy and cardiogenic shock.

Case Report: This is a case of a 58-year-old female with a history of inhaled cannabis use, no history of diabetes, and no known history of cardiac disease, that illustrates an association between cannabis use and the recurrent development of stress cardiomyopathy and cardiogenic shock. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jemermed.2018.12.013DOI Listing
January 2019

Culprit vessel only versus multivessel percutaneous coronary intervention in acute myocardial infarction with cardiogenic shock: A systematic review and meta-analysis.

Cardiovasc Revasc Med 2018 Dec 21. Epub 2018 Dec 21.

Division of Cardiovascular Medicine, East Tennessee State University, Johnson City, TN, USA. Electronic address:

Background: Previous studies comparing outcomes between culprit vessel only percutaneous coronary intervention (CV-PCI) versus multivessel percutaneous coronary intervention (MV-PCI) in patients with cardiogenic shock in the setting of acute myocardial infarction have shown conflicting results. This meta-analysis investigates the optimal approach for management of these patients considering recently published data.

Methods: Electronic databases including MEDLINE, ClinicalTrials. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.carrev.2018.12.015DOI Listing
December 2018

Outcomes after extracorporeal life support for postcardiotomy cardiogenic shock.

J Card Surg 2019 Jan 12. Epub 2019 Jan 12.

Department of Cardiac Surgery, "Louis Pradel" Cardiologic Hospital, "Claude Bernard" University, Lyon, France.

Background And Aim Of The Study: Extracorporeal life support (ECLS) may be necessary in refractory postcardiotomy cardiogenic shock (PCS) unresponsive to optimal medical treatment. We sought to analyze the results and temporal outcomes of ECLS for PCS.

Methods: We performed an observational analysis of our prospective database. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/jocs.13985DOI Listing
January 2019
1 Read

Predicting mortality in patients undergoing VA-ECMO after coronary artery bypass grafting: the REMEMBER score.

Crit Care 2019 Jan 11;23(1):11. Epub 2019 Jan 11.

Center for Cardiac Intensive Care, Beijing Anzhen Hospital, Capital Medical University, Beijing, People's Republic of China.

Background: Prediction scoring systems for coronary artery bypass grafting (CABG) patients on venoarterial extracorporeal membrane oxygenation (VA-ECMO) have not yet been reported. This study was designed to develop a predictive score for in-hospital mortality for cardiogenic shock patients who received VA-ECMO after isolated CABG.

Methods: Retrospective cohort study of consecutive CABG patients supported with VA-ECMO (n = 166) at the Beijing Anzhen Hospital between February 2004 and March 2017. Read More

View Article

Download full-text PDF

Source
https://ccforum.biomedcentral.com/articles/10.1186/s13054-01
Publisher Site
http://dx.doi.org/10.1186/s13054-019-2307-yDOI Listing
January 2019
2 Reads

Predictors of in-hospital mortality in very eldery patients presenting with acute coronary syndrome: A single-center study.

Turk Kardiyol Dern Ars 2019 Jan;47(1):38-44

Department of Cardiology, Pamukkale University Hospitals, Denizli, Turkey.

Objective: Acute coronary syndrome (ACS) has become more frequent in the elderly population due to increased life expectancy. The aim of this trial was to determine clinical and laboratory factors related to in-hospital mortality in patients over 80 years of age who presented with ACS.

Methods: A total 171 patients (86 men, median age 83 years) who were over 80 years of age and were hospitalized due to a diagnosis of ACS were enrolled in this study. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5543/tkda.2018.68792DOI Listing
January 2019
2 Reads

[Therapy of cardiogenic shock : A success story of German cardiology].

Herz 2019 Jan 9. Epub 2019 Jan 9.

Praxis für Innere Medizin und Kardiologie, Maximilianstr. 5a, 63739, Aschaffenburg, Deutschland.

In contrast to the situation in the 1960s and 1970s, the mortality risk for patients with myocardial infarction has been clearly reduced, particularly for those with myocardial infarction with cardiogenic shock (MICS). Approximately 5‑10 % of patients with a myocardial infarction are affected by a MICS and the mortality risk is between 30 % and 50 %. The primary percutaneous coronary intervention with stent implantation should be carried out as quickly as possible in order to reduce the mortality to around 20 %. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00059-018-4773-4DOI Listing
January 2019

The Clinical Potential of Impella 5.0 Support in the Treatment of Recurrent Fulminant Viral Myocarditis with Profound Cardiogenic Shock: A Case Report.

Intern Med 2019 Jan 10. Epub 2019 Jan 10.

Department of Cardiology, Sakakibara Heart Institute, Japan.

We herein report the clinical potential of Impella 5.0 support, which is a catheter-mounted micro-axial left ventricular support device, in a 39-year-old man with recurrent fulminant viral myocarditis complicated with profound cardiogenic shock despite inotropic infusion and an intra-aortic balloon pumping. Switching from these therapies to the Impella 5. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2169/internalmedicine.1866-18DOI Listing
January 2019

Microvascular Thrombosis and Ischaemic Limb Losses in Critically Ill Patients.

Hamostaseologie 2019 Jan 9. Epub 2019 Jan 9.

Department of Pathology and Molecular Medicine, Michael G. DeGroote School of Medicine, McMaster University, Hamilton, Ontario, Canada.

Relatively little scientific attention has been given to the small subset of critically ill patients with circulatory shock who develop ischaemic limb losses (symmetrical peripheral gangrene [SPG]). The clinical picture consists of acral (distal extremity) tissue necrosis involving lower limbs in a largely symmetrical fashion and with detectable arterial pulses; in one-third of patients the upper extremities are also affected (potential for four-limb amputations). The laboratory picture includes thrombocytopenia, coagulopathy, and normoblastemia (circulating nucleated red blood cells). Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1055/s-0038-1676823DOI Listing
January 2019
2 Reads

ST-Elevation Myocardial Infarction in Patients With Malignancies.

Kardiologiia 2018 Dec 25;58(12):5-12. Epub 2018 Dec 25.

Samara State Medical University.

Acute myocardial infarction (MI), the most severe complication of coronary artery disease, develops in 2-4% of patients with various malignancies.

Purpose: to explore the specific properties of ST-segment elevation myocardial infarction (STEMI) course in patients with cancer and its effect on short-term outcome.

Materials And Methods: We included in this study 45 patients with STEMI and history of cancer hospitalized in the period from 01. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18087/cardio.2018.12.10204DOI Listing
December 2018

Incidence and outcome of peri-procedural cardiogenic shock: results from the international Euro Heart Survey PCI registry.

Eur Heart J Acute Cardiovasc Care 2019 Jan 8:2048872618822460. Epub 2019 Jan 8.

1 Department of Cardiology, Justus-Liebig University of Giessen, Germany.

Background:: There is a large body of literature on acute myocardial infarction complicated by cardiogenic shock. However, very little is known about patients who are initially haemodynamically stable and develop cardiogenic shock during percutaneous coronary intervention.

Methods:: A total of 47,407 consecutive patients were prospectively enrolled in the PCI Registry of the Euro Heart Survey Programme. Read More

View Article

Download full-text PDF

Source
http://journals.sagepub.com/doi/10.1177/2048872618822460
Publisher Site
http://dx.doi.org/10.1177/2048872618822460DOI Listing
January 2019
1 Read

Palliative Care Consultation in Cardiogenic Shock Requiring Short-Term Mechanical Circulatory Support: A Retrospective Cohort Study.

J Palliat Med 2019 Jan 7. Epub 2019 Jan 7.

1 Adult Palliative Care, Department of Medicine, Columbia University Medical Center, New York, New York.

Background: Little is known about palliative care consultation (PCC) for patients with cardiogenic shock requiring short-term mechanical circulatory support (STMCS).

Objective: To describe the utilization of PCC in this population.

Design: Retrospective cohort study in a university medical center intensive care unit (ICU). Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1089/jpm.2018.0393DOI Listing
January 2019

Perioperative and Anesthetic Management of Coarctation of the Aorta.

Semin Cardiothorac Vasc Anesth 2019 Jan 7:1089253218821953. Epub 2019 Jan 7.

1 Seattle Children's Hospital, Seattle, WA, USA.

Isolated coarctation of the aorta is a relatively common form of congenital heart disease that is characterized by variable degrees of obstruction to aortic outflow. The clinical presentation varies from asymptomatic arterial hypertension to cardiogenic shock. The treatment options include surgical repair or interventional therapy with aortic balloon dilation and stent placement. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1089253218821953DOI Listing
January 2019
2 Reads

Anticoagulation of a Percutaneous Left Ventricular Assist Device Using a Low-Dose Heparin Purge Solution Protocol: A Case Series.

J Pharm Pract 2019 Jan 6:897190018822105. Epub 2019 Jan 6.

1 Department of Clinical and Administrative Pharmacy, University of Georgia College of Pharmacy, Augusta, GA, USA.

Background:: Impella CP® is a percutaneous left ventricular assist device that requires a heparin-dextrose purge solution. The manufacturer recommends heparin 50 units/mL, but supratherapeutic anticoagulation has been observed with this concentration.

Objective:: The purpose of this evaluation was to observe the efficacy and safety of a low-dose heparin-based purge solution (25 units/mL in dextrose 20%). Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/0897190018822105DOI Listing
January 2019

Rapid Aspirin Desensitization is Safe and Feasible in Patients With Stable and Unstable Coronary Artery Disease: A Single-Center Experience.

J Cardiovasc Pharmacol Ther 2019 Jan 6:1074248418823016. Epub 2019 Jan 6.

1 Cardiology Department, The James Cook University Hospital, Middlesbrough, United Kingdom.

Aims:: There are limited data on aspirin (ASA) desensitization for patients with coronary disease. We present our experience with a rapid nurse-led oral desensitization regimen in patients with aspirin sensitivity undergoing coronary angiography.

Methods:: This single-center retrospective observational study includes patients with a history of ASA sensitivity undergoing coronary angiography with intent to perform percutaneous coronary intervention (PCI). Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1074248418823016DOI Listing
January 2019

Hospitalisation and life support in the year before and during heart transplantation: a French national study.

Open Heart 2018 9;5(2):e000913. Epub 2018 Dec 9.

Département d'Etudes sur les Pathologies et les Patients (DEPP), Caisse Nationale d'Assurance Maladie, Paris, France.

Objective: The objective of this study was to define the characteristics of hospital care use during the year prior to heart transplantation.

Methods: A retrospective cohort of heart transplant recipients registered on the national hospital discharge database between 2010 and 2015 was analysed.

Results: In this cohort of 2379 heart transplant recipients (mean age: 48 years, 74% men), 91% had been admitted at least once, for at least 1 day, to a short-stay hospital during the year before transplantation (mean: 4. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/openhrt-2018-000913DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6307614PMC
December 2018

Protein-Energy Malnutrition and Outcomes of Hospitalizations for Heart Failure in the USA.

Am J Cardiol 2018 Dec 19. Epub 2018 Dec 19.

Associate Professor of Medicine, WJB Dorn VAMC Heart and Vascular Institute/USC School of Medicine, Columbia, South Carolina.

Chronically elevated cytokines from un-abating low-grade inflammation in heart failure (HF) results in Protein-Energy Malnutrition (PEM). However, the impact of PEM on clinical outcomes of admissions for HF exacerbations has not been evaluated in a national data. From the 2012 to 2014 Nationwide Inpatient Sample (NIS) patient's discharge records for primary HF admissions, we identified patients with concomitant PEM, and their demographic and comorbid factors. Read More

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S00029149183220
Publisher Site
http://dx.doi.org/10.1016/j.amjcard.2018.12.014DOI Listing
December 2018
2 Reads

Early and Long-Term Outcomes in Patients Undergoing Cardiac Surgery Following Iatrogenic Injuries During Percutaneous Coronary Intervention.

J Am Heart Assoc 2019 Jan;8(1):e010940

1 University department of Cardiac Surgery Leipzig Heart Center Germany.

Background Iatrogenic coronary artery injuries during percutaneous coronary interventions ( PCI ) often require emergent surgical management. Our study evaluated the early and long-term outcomes in patients undergoing surgical treatment of iatrogenic PCI complications and identified the predictors of operative and long-term mortality. Methods and Results Pre-, intra- and post-operative data and hospital outcomes of 168 consecutive patients undergoing cardiac surgical procedures for iatrogenic complications following PCI between December 1999 and July 2015, were prospectively collected in our computerized database. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/JAHA.118.010940DOI Listing
January 2019

Hospital Variation in the Utilization of Short-Term Nondurable Mechanical Circulatory Support in Myocardial Infarction Complicated by Cardiogenic Shock.

Circ Cardiovasc Interv 2019 Jan;12(1):e007270

Richard A. and Susan F. Smith Center for Cardiovascular Outcomes Research, Division of Cardiovascular Medicine, Beth Israel Deaconess Medical Center, Boston, MA (J.B.S., Y.Z., C.S., M.C., D.S.P., J.J.P., R.W.Y.).

Background: Limited knowledge exists on inter-hospital variation in the utilization of short-term, nondurable mechanical circulatory support (MCS) for myocardial infarction (MI) complicated by cardiogenic shock (CS).

Methods And Results: Hospitalizations for MI with CS in 2014 in a nationally representative all-payer database were included. The proportion of hospitalizations for MI with CS using MCS (MCS ratio) and in-hospital mortality were evaluated. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/CIRCINTERVENTIONS.118.007270DOI Listing
January 2019

Extra corporeal membrane oxygenation in the critical trauma patient.

Curr Opin Anaesthesiol 2019 Jan 2. Epub 2019 Jan 2.

Department of Anaeshesia and Intensive Care, University La Sapienza, Rome, Italy.

Purpose Of Review: The purpose of this review is to describe recent evidence regarding the use of extracorporeal membrane oxygenation (ECMO) as salvage therapy for severe cardiac or respiratory failure in patients with trauma. The characteristics of this cohort of patients, including the risk of bleeding and the need for systemic anticoagulation, are generally considered as relative contraindications to ECMO treatment. However, recent evidence suggests that the use of ECMO should be taken in consideration even in this group of patients. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/ACO.0000000000000698DOI Listing
January 2019
1 Read

In-Hospital Management and Outcomes After ST-Segment-Elevation Myocardial Infarction in Medicaid Beneficiaries Compared With Privately Insured Individuals.

Circ Cardiovasc Qual Outcomes 2019 Jan;12(1):e004971

Division of Cardiovascular Disease, University of Alabama at Birmingham Birmingham, AL (N.P., N.S.B., G.A., P.A.).

Background: Medicaid expansion among previously uninsured individuals has led to improved healthcare access. However, considerably lower reimbursement rates of Medicaid have raised concerns on the unintended consequence of lower utilization of life-saving therapies and inferior outcomes compared with private insurance. We examined the rates of revascularization and in-hospital mortality among Medicaid beneficiaries versus privately insured individuals hospitalized with ST-segment-elevation myocardial infarction (STEMI). Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/CIRCOUTCOMES.118.004971DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6322423PMC
January 2019
1 Read

Urgent Surgical Treatment of Aortic Endocarditis in Infants and Children.

Pediatr Cardiol 2019 Jan 2. Epub 2019 Jan 2.

Department of Pediatric Cardiology, Schneider Children's Medical Center of Israel, Petach Tikva, Israel.

Infective endocarditis (IE) in the pediatric population can present as a life-threatening condition. Optimal timing for surgical intervention should consider surgical risks versus the risk of neurologic complications. We herein report our experience with this group of critically ill children. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00246-018-2030-5DOI Listing
January 2019
1 Read

Percutaneous left ventricular assist device . intra-aortic balloon pump in patients with severe left ventricular dysfunction undergoing cardiovascular intervention: A meta-analysis.

Chronic Dis Transl Med 2018 Dec 12;4(4):260-267. Epub 2018 Apr 12.

Department of Cardiology, Provincial Hospital Affiliated to Shandong University, Jinan, Shandong 250021, China.

Objective: Although controversial, the intra-aortic balloon pump (IABP) and percutaneous left ventricular assist device (PLVAD) are widely used for initial hemodynamic stabilization. We performed a meta-analysis to compare the clinical outcomes of these two devices in patients with severe left ventricular (LV) dysfunction undergoing percutaneous coronary intervention (PCI) or ventricular tachycardia (VT) ablation.

Methods: MEDLINE, EMBASE, the Cochrane Registry of Controlled Trials, and reference lists of relevant articles were searched. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cdtm.2017.11.002DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6308918PMC
December 2018
1 Read

Long-term survival in patients presenting with STEMI complicated by out of hospital cardiac arrest.

Int J Cardiol Heart Vasc 2019 Mar 20;22:50-54. Epub 2018 Dec 20.

Department of Cardiology, Westmead Hospital, Sydney, Australia.

Background: There is limited data regarding long-term survival in patients who present with STEMI and out of hospital cardiac arrest (OHCA).

Methods: We prospectively analysed outcomes in 3521 consecutive patients who were diagnosed with STEMI and underwent primary percutaneous coronary intervention (PPCI) or coronary artery bypass surgery from 2004 to 2017. They were divided into two groups according to the presence of cardiac arrest (group I, patients with cardiac arrest;  = 156 group II, patients without cardiac arrest;  = 3365). Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijcha.2018.12.001DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6305836PMC
March 2019
1 Read

Blood Lactate as a Reliable Marker for Mortality of Pediatric Refractory Cardiogenic Shock Requiring Extracorporeal Membrane Oxygenation.

Pediatr Cardiol 2019 Jan 2. Epub 2019 Jan 2.

Department of Extracorporeal Circulation and Extracorporeal Life Support, Heart Institute, Zhejiang University School of Medicine Children's Hospital, 3333 Binsheng Road, Binjiang District, Hangzhou, Zhejiang, People's Republic of China.

The objective of this study is to establish reliable markers for mortality in children with refractory cardiogenic shock who underwent extracorporeal membrane oxygenation. A retrospective observational cohort study was performed at academic children's hospital for forty-three consecutive pediatric patients who required veno-arterial extracorporeal membrane oxygenation (ECMO) support with refractory cardiogenic shock from January 2011 to October 2017. 30-day mortality in this cohort was 39. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00246-018-2033-2DOI Listing
January 2019
1 Read

ECMO-treatment in patients with acute lung failure, cardiogenic, and septic shock: mortality and ECMO-learning curve over a 6-year period.

J Intensive Care 2018 18;6:84. Epub 2018 Dec 18.

1Department of Visceral and Thoracic Surgery, Asklepios Klinik Langen, Röntgenstr 20, 63220 Langen, Germany.

Background: Based on promising results over the past 10 years, the method of extracorporeal membrane oxygenation (ECMO) has developed from being used as a 'rescue therapy' to become an accepted treatment option for patients with acute lung failure (ARDS). Subsequently, the indication was extended also to patients suffering from cardiogenic and septic shock. Our aim was to evaluate hospital mortality and associated prognostic variables in patients with lung failure, cardiogenic, and septic shock undergoing ECMO. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s40560-018-0352-2DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6299557PMC
December 2018
2 Reads

Improving Care of STEMI in the United States 2008 to 2012.

J Am Heart Assoc 2019 Jan;8(1):e008096

11 Department of Medicine Boston University School of Medicine Boston MA.

Background We aimed to determine the change in treatment strategies and times to treatment over the first 5 years of the Mission: Lifeline program. Methods and Results We assessed pre- and in-hospital care and outcomes from 2008 to 2012 for patients with ST -segment-elevation myocardial infarction at US hospitals, using data from the National Cardiovascular Data Registry Acute Coronary Treatment and Intervention Outcomes Network Registry-Get With The Guidelines Registry. In-hospital adjusted mortality was calculated including and excluding cardiac arrest as a reason for primary percutaneous coronary intervention delay. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/JAHA.118.008096DOI Listing
January 2019
1 Read

Acute tension pneumopericardium due to perforated gastric ulcer without diagnostic radiographic findings 72 h before perforation.

J Cardiol Cases 2018 Dec 2;18(6):201-203. Epub 2018 Oct 2.

Department of Cardiology, Helios University Hospital and University of Witten/Herdecke, Wuppertal, Germany.

Introduction: Acute tension pneumopericardium due to gastric perforation is a rare and often lethal condition. Only a few case reports have been described in the literature. Diagnosis based on clinical evaluation is difficult and it is usually made incidentally upon computed tomography (CT) or plain radiography of the chest. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jccase.2018.07.007DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6306572PMC
December 2018
1 Read

Acute papillary muscle rupture immediately after ST-segment elevation acute myocardial infarction: A case report.

J Cardiol Cases 2018 Dec 7;18(6):189-191. Epub 2018 Dec 7.

Hyogo Prefectural Awaji Medical Center, Japan.

A 73-year-old woman in cardiogenic shock was referred to our hospital because of papillary muscle rupture immediately after the onset of acute myocardial infarction (MI). She had undergone emergent percutaneous coronary intervention and mitral valve replacement. Serial creatine kinase and creatine kinase MB levels indicated that she had acute phase MI on arrival. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jccase.2018.07.009DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6306573PMC
December 2018
1 Read

Trends in the utilization and in-hospital mortality associated with pulmonary artery catheter use for cardiogenic shock hospitalizations.

Indian Heart J 2018 Dec 5;70 Suppl 3:S496-S498. Epub 2018 Sep 5.

Department of Cardiology, North Shore University Hospital, Northwell Health, Manhasset, NY, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ihj.2018.08.021DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6309713PMC
December 2018
1 Read

Predictors of short-term outcomes in patients undergoing percutaneous coronary intervention in cardiogenic shock complicating STEMI-A tertiary care center experience.

Indian Heart J 2018 Dec 10;70 Suppl 3:S259-S264. Epub 2018 Apr 10.

Department of Cardiology, Institute of Cardio-Vascular Diseases, Madras Medical Mission, Chennai, India. Electronic address:

Background: Studying the outcomes in patients presenting with cardiogenic shock with ST-segment elevation myocardial infarction (CS-STEMI) and undergoing primary or rescue percutaneous coronary intervention (PCI) may give an insight to the unmet needs in STEMI-care in our region and may help in future recommendations in improving survival.

Materials And Methodolgy: During the period from January 2001- June 2017, there were 114 patients included in the study. The demographic, clinical and angiographic characteristics were compared between the survivors and non-survivors. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ihj.2018.03.006DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6309147PMC
December 2018
1 Read

Outcomes of multivessel vs culprit lesion-only percutaneous coronary intervention in patients with acute myocardial infarction complicated by cardiogenic shock: Evidence from an updated meta-analysis.

Catheter Cardiovasc Interv 2018 Dec 28. Epub 2018 Dec 28.

Division of Cardiovascular Medicine, University of Massachusetts Medical School, Worcester, Massachusetts.

Objectives: This updated meta-analysis evaluated outcomes with multi-vessel (MV-PCI) vs culprit lesion-only percutaneous coronary intervention (CL-PCI), in patients with acute myocardial infarction (AMI) complicated by cardiogenic shock (CS).

Background: There is considerable debate regarding the optimal revascularization strategy in patients with AMI and CS, particularly regarding management of non-culprit lesions.

Methods: Databases were searched for studies comparing MV-PCI and CL-PCI in patients with AMI and CS. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ccd.28062DOI Listing
December 2018
1 Read

Blood lactate and lactate kinetics as treatment and prognosis markers for tissue hypoperfusion.

Acta Clin Belg 2018 Dec 28:1-8. Epub 2018 Dec 28.

a Faculty of Medicine and Health Sciences , Ghent University , Ghent , Belgium.

Objective: Blood lactate concentration (L) and lactate kinetic (LK) over time might be a helpful marker of the shock severity. The purpose of this study is to analyze whether the L and LK could correlate with the outcome and the therapy of patients with different types of shock.

Methods: Design: A 3. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/17843286.2018.1560612DOI Listing
December 2018
1 Read

Surgical Repair of Aortocaval Fistula Presenting with Cardiogenic Shock.

Korean J Thorac Cardiovasc Surg 2018 Dec 5;51(6):406-409. Epub 2018 Dec 5.

Department of Thoracic and Cardiovascular Surgery, Inje University Haeundae Paik Hospital, Inje University College of Medicine.

Aortocaval fistula (ACF) occurs in <1% of all abdominal aortic aneurysms (AAAs), and in 3% to 7% of all ruptured AAAs. The triad of clinical findings of AAA with ACF are abdominal pain, abdominal machinery bruit, and a pulsating abdominal mass. Other findings include pelvic venous hypertension (hematuria, oliguria, scrotal edema), lower-limb edema with or without arterial insufficiency or venous thrombus, shock, congestive heart failure, and cardiac arrest. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5090/kjtcs.2018.51.6.406DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6301325PMC
December 2018
1 Read

Another Nail in the Coffin for Intra-Aortic Balloon Counterpulsion in Acute Myocardial Infarction With Cardiogenic Shock.

Circulation 2019 Jan;139(3):404-406

Cardiovascular Clinical Research Center, Division of Cardiology, Department of Medicine, New York University School of Medicine, NYU Langone Health, New York, NY.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/CIRCULATIONAHA.118.038279DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6331234PMC
January 2019
1 Read

Impella Support for Acute Myocardial Infarction complicated by Cardiogenic Shock: A Matched-Pair IABP-SHOCK II Trial 30-Day Mortality Analysis.

Circulation 2018 Dec 5. Epub 2018 Dec 5.

Clinic for General and interventional Cardiology, University Heart Center Hamburg, Germany.

Background: Percutaneous mechanical circulatory support devices are increasingly used in acute myocardial infarction complicated by cardiogenic shock (AMI-CS), despite limited evidence for their effectiveness. The aim of this study was to evaluate outcomes associated with use of the Impella device compared with IABP and medical treatment in patients with AMI-CS.

Methods: Data of patients with AMI-CS treated with the Impella device at European tertiary care hospitals was collected retrospectively. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/CIRCULATIONAHA.118.036614DOI Listing
December 2018
10 Reads

Unloading the Left Ventricle Before Reperfusion in Patients With Anterior ST-Segment-Elevation Myocardial Infarction.

Circulation 2019 Jan;139(3):337-346

Spectrum Health, Grand Rapids, MI (R.D.M., D.H.W.W.).

Background: In ST-segment-elevation myocardial infarction (STEMI), infarct size correlates directly with heart failure and mortality. Preclinical testing has shown that, in comparison with reperfusion alone, mechanically unloading the left ventricle (LV) before reperfusion reduces infarct size and that 30 minutes of unloading activates a cardioprotective program that limits reperfusion injury. The DTU-STEMI pilot trial (Door-To-Unload in STEMI Pilot Trial) represents the first exploratory study testing whether LV unloading and delayed reperfusion in patients with STEMI without cardiogenic shock is safe and feasible. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/CIRCULATIONAHA.118.038269DOI Listing
January 2019
1 Read

Intraaortic Balloon Pump in Cardiogenic Shock Complicating Acute Myocardial Infarction: Long-Term 6-Year Outcome of the Randomized IABP-SHOCK II Trial.

Circulation 2018 Nov 11. Epub 2018 Nov 11.

Department of Cardiology, Angiology and Intensive Care Medicine, University Heart Center Luebeck, GERMANY.

Background: The role of intraaortic balloon counterpulsation (IABP) in cardiogenic shock is still a subject of intense debate despite the neutral results of the IABP-SHOCK II trial (Intraaortic Balloon Pump in Cardiogenic Shock II) with subsequent downgrading in international guidelines. So far, randomized data on the impact of IABP on long-term clinical outcomes in patients with cardiogenic shock complicating acute myocardial infarction are lacking. Furthermore, only limited evidence is available on general long-term outcomes of patients with cardiogenic shock treated by contemporary practice. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/CIRCULATIONAHA.118.038201DOI Listing
November 2018

Outcomes Associated With Cardiogenic Shock in Takotsubo Syndrome.

Circulation 2019 Jan;139(3):413-415

Department of Cardiology, University Heart Center, University Hospital Zurich, Switzerland (D.D.V., V.L.C., K.K., S.G., K.A.S., J.M., S.J., K.J.D., B.B., M.S., A.C., F.R., J.R.G., C.T.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/CIRCULATIONAHA.118.036164DOI Listing
January 2019
3 Reads
14.430 Impact Factor

Prevention of Cardiogenic Shock After Acute Myocardial Infarction.

Circulation 2019 Jan;139(1):137-139

Department of Cardiovascular Sciences (M.V., P.R.S., F.V.d.W.), KU Leuven, Belgium.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/CIRCULATIONAHA.118.036536DOI Listing
January 2019

Extracorporeal Membrane Oxygenation Use in Cardiogenic Shock: Impact of Age on In-Hospital Mortality, Length of Stay, and Costs.

Crit Care Med 2018 Dec 21. Epub 2018 Dec 21.

Richard A. and Susan F. Smith Center for Outcomes Research in Cardiology, Division of Cardiovascular Medicine, Department of Medicine, Beth Israel Deaconess Medical Center, Boston, MA.

Objectives: Increasing age is a well-recognized risk factor for in-hospital mortality in patients receiving extracorporeal membrane oxygenation for cardiogenic shock, but the shape of this relationship is unknown. In addition, the impact of age on hospital length of stay, patterns of patient disposition, and costs has been incompletely characterized.

Design: Retrospective analysis of the National Inpatient Sample. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/CCM.0000000000003631DOI Listing
December 2018
1 Read

[Predictors of one-year outcomes after percutaneous coronary interventions in octogenarian patients with acute coronary syndrome.]

Adv Gerontol 2018 ;31(3):394-399

I.M.Sechenov First Moscow State Medical University, 2/4, Bolshaya Pirogovskaya str., Moscow, 119991, Russian Federation; e-mail:

Our study presented the long-term outcomes of coronary stenting and predictors of two-year outcomes in octogenarian patients with acute coronary syndrome. A total of 366 patients with STEMI, NSTEMI and unstable angina undergoing percutaneous coronary intervention (PCI). Results were assessed at a median follow up of 20 months. Read More

View Article

Download full-text PDF

Source
January 2018
1 Read